Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released its 2026 Drugs to Watch ...
Anticipated advancements in weight loss, diabetes, oncology, rare conditions and protein degraders poised to reshape patient careLONDON, Jan. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ...
New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia ...
The festive period brought some unwanted post for both Sanofi and Corcept Therapeutics in the form of FDA rejections for the companies’ respective drug applications. Sanofi revealed Dec. 24 that the ...
An estimated 3 million Americans have an inflammatory bowel disease (IBD) such as Crohn's disease or ulcerative colitis. But ...
Amy Schumer has lost a considerable amount of weight over the past few months—over 50 pounds to date—and says that her weight loss journey was brought on by her Cushing Syndrome diagnosis, saying she ...
The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.
Treatment with atumelnant resulted in rapid, sustained lowering of androstenedione (in all eight patients that completed the fourth cohort). Seven out of these eight patients continued to maintain ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The same drug is under FDA ...
Dechra Announces FDA Approval of Zygolide® (pergolide tablets) for the Control of Clinical Signs Associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in Horses Zygolide® is ...
Amy Schumer is kicking off the new year with a positive and healthy mindset. The Kinda Pregnant star, 44, took to Instagram on Sunday, January 4, to show off her recent weight loss, sharing a string ...
The FDA has approved pergolide tablets (Zygolide; Dechra) for controlling clinical signs associated with pituitary pars intermedia dysfunction (PPID) in horses, also known as equine Cushing disease.